Crosslinked urethane doped polyester biphasic scaffolds: Potential for in vivo vascular tissue engineering

Journal of Biomedical Materials Research - Part A

Volumn 95 A, Issue 2, 2010, Pages 361-370

  Dey, Jagannath ^a,b   Xu, Hao ^a,b   Nguyen, Kytai Truong ^a,b   Yang, Jian ^a,b  

^a The University of Texas at Arlington   (United States)

^b UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

biodegradable elastomer; hemocompatibility; scaffold; vascular tissue engineering

Indexed keywords

BIODEGRADABLE ELASTOMERS; BIPHASIC SCAFFOLDS; BURST PRESSURES; CROSSLINKED; GRAFT FAILURE; GRAFT MATERIALS; HEMOCOMPATIBILITY; IN-VITRO; IN-VIVO; INFLAMMATORY CYTOKINES; MECHANICAL STRENGTH; PLLA; POLY L LACTIC ACID; STRINGENT REQUIREMENT; TARGET TISSUES; TISSUE REGENERATION; TISSUE SCAFFOLDS; VASCULAR GRAFTS; VASCULAR TISSUE ENGINEERING; WHOLE BLOOD;

BIODEGRADABLE POLYMERS; BIOMECHANICS; BLOOD; BLOOD VESSELS; CELL CULTURE; CROSSLINKING; ELASTOMERS; ENGINEERING; GRAFTS; LACTIC ACID; MECHANICAL PROPERTIES; ORGANIC POLYMERS; SCAFFOLDS; TENSILE STRENGTH; TISSUE;

TISSUE ENGINEERING;

CROSSLINKED URETHANE DOPED POLYESTER; INTERLEUKIN 1BETA; POLYLACTIC ACID; TISSUE SCAFFOLD; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARGON PLASMA COAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL GRAFT; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RELEASE; HEMOLYSIS; IN VIVO STUDY; LEUKOCYTE ACTIVATION; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE STRUCTURE; VASCULAR TISSUE;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; CROSS-LINKING REAGENTS; HEMOLYSIS; HUMANS; INTERLEUKIN-1BETA; LEUKOCYTES; MATERIALS TESTING; POLYESTERS; REGENERATION; STRESS, MECHANICAL; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TUMOR NECROSIS FACTOR-ALPHA; URETHANE;

EID: 78649304346     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32846     Document Type: Article

References (71)

1. Conte MS,. The ideal small arterial substitute: A search for the Holy Grail? FASEB J 1998; 12: 43-45.
2. Teebken OE, Haverich A,. Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg 2002; 23: 475-485. (Pubitemid 41079396)
3. Baguneid MS, Seifalian AM, Salacinski HJ, Murray D, Hamilton G, Walker MG,. Tissue engineering of blood vessels. Br J Surg 2006; 93: 282-290.
4. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y,. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-e146.
5. Xue L, Greisler HP,. Biomaterials in the development and future of vascular grafts. J Vasc Surg 2003; 37: 472-480.
6. Boswell CA, Williams SK,. Denucleation promotes neovascularization of ePTFE in vivo. J Biomat Sci Polym Ed 1999; 10: 319-329.
7. Katz DA, Haimovich B, Greco RS,. Neutrophil activation by expanded polytetrafluoroethylene is dependent on the induction of protein phosphorylation. Surgery 1994; 116: 446-454.
8. Chevallier P, Janvier R, Mantovani D, Laroche G,. In vitro biological performances of phosphorylcholine-grafted ePTFE prostheses through RFGD plasma techniques. Macromol Biosci 2005; 5: 829-839.
9. Begovac PC, Thomson RC, Fisher JL, Hughson A, Gallhagen A,. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization. Eur J Vasc Endovasc Surg 2003; 25: 432-437.
10. Dardik H, Ibrahim IM, Sussman B, Kahn M, Sanchez M, Klausner S, Baier RE, Meyer AE, Dardik II,. Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy. Ann Surg 1984; 199: 61-68.
11. Dardik H,. The second decade of experience with the umbilical vein graft for lower-limb revascularization. Cardiovasc Surg 1995; 3: 265-269.
12. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE, Jr,. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 1035-1040.
13. Huynh T, Abraham G, Murray J, Brockbank K, Hagen PO, Sullivan S,. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 1999; 17: 1083-1086.
14. Isenberg BC, Williams C, Tranquillo RT,. Small-diameter artificial arteries engineered in vitro. Circ Res 2006; 98: 25-35.
15. Nemcova S, Noel AA, Jost CJ, Gloviczki P, Miller VM, Brockbank KG,. Evaluation of a xenogeneic acellular collagen matrix as a small-diameter vascular graft in dogs-preliminary observations. J Invest Surg 2001; 14: 321-330.
16. Seliktar D, Black RA, Vito RP, Nerem RM,. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 2000; 28: 351-362.
17. Grassl ED, Oegema TR, Tranquillo RT,. Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. J Biomed Mater Res A 2002; 60: 607-612.
18. Arrigoni C, Camozzi D, Imberti B, Mantero S, Remuzzi A,. The effect of sodium ascorbate on the mechanical properties of hyaluronan-based vascular constructs. Biomaterials 2006; 27: 623-630.
19. Couet F, Rajan N, Mantovani D,. Macromolecular biomaterials for scaffold-based vascular tissue engineering. Macromol Biosci 2007; 7: 701-718.
20. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R,. Functional arteries grown in vitro. Science 1999; 284: 489-493.
21. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE, Jr,. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998; 115: 536-545; discussion 545-546.
22. Brennan MP, Dardik A, Hibino N, Roh JD, Nelson GN, Papademitris X, Shinoka T, Breuer CK,. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg 2008; 248: 370-376.
23. van der Lei B, Bartels HL, Nieuwenhuis P, Wildevuur CR,. Microporous, complaint, biodegradable vascular grafts for the regeneration of the arterial wall in rat abdominal aorta. Surgery 1985; 98: 955-963.
24. Watanabe M, Shin'oka T, Tohyama S, Hibino N, Konuma T, Matsumura G, Kosaka Y, Ishida T, Imai Y, Yamakawa M, Ikada Y, Morita S,. Tissue-engineered vascular autograft: Inferior vena cava replacement in a dog model. Tissue Eng 2001; 7: 429-439.
25. Iwai S, Sawa Y, Ichikawa H, Taketani S, Uchimura E, Chen G, Hara M, Miyake J, Matsuda H,. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. J Thorac Cardiovasc Surg 2004; 128: 472-479.
26. Shin'oka T, Imai Y, Ikada Y,. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001; 344: 532-533.
27. Lee SJ, Liu J, Oh SH, Soker S, Atala A, Yoo JJ,. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 2008; 29: 2891-2898.
28. Hoerstrup SP, Zund G, Sodian R, Schnell AM, Grunenfelder J, Turina MI,. Tissue engineering of small caliber vascular grafts. Eur J Cardiothorac Surg 2001; 20: 164-169.
29. Soletti L, Hong Y, Guan J, Stankus JJ, El-Kurdi MS, Wagner WR, Vorp DA,. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater 2009; 6: 110-122.
30. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA,. A completely biological tissue-engineered human blood vessel. FASEB J 1998; 12: 47-56.
31. McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, Zagalski K, Fiorillo A, Avila H, Manglano X, Antonelli J, Kocher A, Zembala M, Cierpka L, de la Fuente LM, L'Heureux N,. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 373: 1440-1446.
32. Vorp DA, Maul T, Nieponice A,. Molecular aspects of vascular tissue engineering. Front Biosci 2005; 10: 768-789.
33. Girton TS, Oegema TR, Grassl ED, Isenberg BC, Tranquillo RT,. Mechanisms of Stiffening and Strengthening in Media-Equivalents Fabricated Using Glycation. J Biomed Eng 2000; 122: 216.
34. Haruguchi H, Teraoka S,. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review. J Artif Organs 2003; 6: 227-235.
35. Stitzel J, Liu J, Lee SJ, Komura M, Berry J, Soker S, Lim G, Van Dyke M, Czerw R, Yoo JJ, Atala A,. Controlled fabrication of a biological vascular substitute. Biomaterials 2006; 27: 1088-1094.
36. Xu CY, Inai R, Kotaki M, Ramakrishna S,. Aligned biodegradable nanofibrous structure: A potential scaffold for blood vessel engineering. Biomaterials 2004; 25: 877-886.
37. Mo XM, Xu CY, Kotaki M, Ramakrishna S,. Electrospun P(LLA-CL) nanofiber: A biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials 2004; 25: 1883-1890.
38. Smith MJ, McClure MJ, Sell SA, Barnes CP, Walpoth BH, Simpson DG, Bowlin GL,. Suture-reinforced electrospun polydioxanone-elastin small-diameter tubes for use in vascular tissue engineering: A feasibility study. Acta Biomater 2008; 4: 58-66.
39. Sell SA, McClure MJ, Barnes CP, Knapp DC, Walpoth BH, Simpson DG, Bowlin GL,. Electrospun polydioxanone-elastin blends: Potential for bioresorbable vascular grafts. Biomed Mater 2006; 1: 72-80.
40. Nieponice A, Soletti L, Guan J, Deasy BM, Huard J, Wagner WR, Vorp DA,. Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials 2008; 29: 825-833.
41. Pektok E, Nottelet B, Tille JC, Gurny R, Kalangos A, Moeller M, Walpoth BH,. Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 2008; 118: 2563-2570.
42. Tran RT, Zhang Y, Dipendra G, Yang J,. Recent developments on citric acid derived biodegradable elastomers. Recent Pat Biomed Eng 2009; 2: 216-227.
43. Yang J, Webb AR, Ameer GA,. Novel citric acid-based biodegradable elastomers for tissue engineering. Adv Mater 2006; 16: 511-516.
44. Wang Y, Ameer GA, Sheppard BJ, Langer R,. A tough biodegradable elastomer. Nat Biotechnol 2002; 20: 602-606.
45. Yang J, Motlagh D, Webb AR, Ameer GA,. Novel biphasic elastomeric scaffold for small-diameter blood vessel tissue engineering. Tissue Eng 2005; 11: 1876-1886.
46. Yang J, Webb AR, Pickerill SJ, Hageman G, Ameer GA,. Synthesis and evaluation of poly(diol citrate) biodegradable elastomers. Biomaterials 2006; 27: 1889-1898.
47. Motlagh D, Yang J, Lui KY, Webb AR, Ameer GA,. Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials 2006; 27: 4315-4324.
48. Yang J, Motlagh D, Allen J, Webb AR, Kibbe MR, Aalami O, Kapadia M, Carroll TJ, Ameer GA,. Modulating expanded polytetrafluoroethylene vascular graft host response via citric acid-based biodegradable elastomers. Adv Mater 2006; 18: 1493-1498.
49. Dey J, Xu H, Shen J, Thevenot P, Gondi SR, Nguyen KT, Sumerlin BS, Tang L, Yang J,. Development of biodegradable crosslinked urethane-doped polyester elastomers. Biomaterials 2008; 29: 4637-4649.
50. Huang N, Yang P, Leng YX, Chen JY, Sun H, Wang J, Wang GJ, Ding PD, Xi TF, Leng Y,. Hemocompatibility of titanium oxide films. Biomaterials 2003; 24: 2177-2187.
51. Motlagh D, Allen J, Hoshi R, Yang J, Lui KY, Ameer GA,. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J Biomed Mater Res A 2007; 82: 907-916.
52. Weinberg CB, Bell E,. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231: 397-400.
53. Lommen E, Goglewski S, Pennings A, Wildevuur C, Nieuwenhuis P,. Development of a neo-artery induced by a biodegradable polymeric vascular prosthesis. ASAIO J 1983; 29: 255-259.
54. Nerem R,. Tissue engineering a blood vessel substitute: The role of biomechanics. Yonsei Med J 2000; 21: 735-739.
55. Bassiouny HS, White S, Glagov S, Choi E, Giddens DP, Zarins CK,. Anastomotic intimal hyperplasia: Mechanical injury or flow induced. J Vasc Surg 1992; 15: 708-716; discussion 716-717.
56. Trubel W, Moritz A, Schima H, Raderer F, Scherer R, Ullrich R, Losert U, Polterauer P,. Compliance and formation of distal anastomotic intimal hyperplasia in Dacron mesh tube constricted veins used as arterial bypass grafts. ASAIO J 1994; 40: M273-M278.
57. Lemson MS, Tordoir JH, Daemen MJ, Kitslaar PJ,. Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg 2000; 19: 336-350.
58. He H, Matsuda T,. Arterial replacement with compliant hierarchic hybrid vascular graft: Biomechanical adaptation and failure. Tissue Eng 2002; 8: 213-224.
59. Tiwari A, Cheng KS, Salacinski H, Hamilton G, Seifalian AM,. Improving the patency of vascular bypass grafts: The role of suture materials and surgical techniques on reducing anastomotic compliance mismatch. Eur J Vasc Endovasc Surg 2003; 25: 287-295.
60. Greenwald SE, Berry CL,. Improving vascular grafts: The importance of mechanical and haemodynamic properties. J Pathol 2000; 190: 292-299.
61. Holzapfel GA, Sommer G, Gasser CT, Regitnig P,. Determination of layer-specific mechanical properties of human coronary arteries with nonatherosclerotic intimal thickening and related constitutive modeling. Am J Physiol Heart Circ Physiol 2005; 289: H2048-H2058.
62. Laurent S, Girerd X, Mourad JJ, Lacolley P, Beck L, Boutouyrie P, Mignot JP, Safar M,. Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscl Thromb Vasc 1994; 14: 1223.
63. Konig G, McAllister TN, Dusserre N, Garrido SA, Iyican C, Marini A, Fiorillo A, Avila H, Wystrychowski W, Zagalski K, Maruszewski M, Jones AL, Cierpka L, de la Fuente LM, L'Heureux N,. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 2009; 30: 1542-1550.
64. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN,. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-365.
65. Tang L, Ugarova TP, Plow EF, Eaton JW,. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest 1996; 97: 1329-1334.
66. Muller WA,. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 2003; 24: 327-334.
67. Solovjov DA, Pluskota E, Plow EF,. Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem 2005; 280: 1336-1345.
68. Nguyen KT, Su SH, Sheng A, Wawro D, Schwade ND, Brouse CF, Greilich PE, Tang L, Eberhart RC,. In vitro hemocompatibility studies of drug-loaded poly-(L -lactic acid) fibers. Biomaterials 2003; 24: 5191-5201.
69. Suska F, Esposito M, Gretzer C, Kalltorp M, Tengvall P, Thomsen P,. IL-1alpha. IL-1beta and TNF-alpha secretion during in vivo/ex vivo cellular interactions with titanium and copper. Biomaterials 2003; 24: 461-468.
70. DeFife KM, Yun JK, Azeez A, Stack S, Ishihara K, Nakabayashi N, Colton E, Anderson JM,. Adhesion and cytokine production by monocytes on poly(2-methacryloyloxyethyl phosphorylcholine-co-alkyl methacrylate)-coated polymers. J Biomed Mater Res 1995; 29: 431-439.
71. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T,. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 2003; 24: 1121-1131.